Gabrail Cancer Center Research — Canton, Ohio

Public research footprint of Gabrail Cancer Center Research, compiled from the ClinicalTrials.gov public registry.

128

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Myelofibrosis Due to and Following Polycythemia Vera · Carcinoma, Non-Small-Cell Lung (NSCLC) · Relapsed/Refractory Follicular Lymphoma

Recently updated registry entries

NCT04224493 — A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of… (Active Not Recruiting)
NCT04093570 — A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard… (Enrolling By Invitation)
NCT05727176 — Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Gabrail Cancer Center Research?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.